About Evvy
Evvy is a company based in New York (United States) founded in 2002 by Priyanka Jain. Evvy has raised $19 million across 2 funding rounds from investors including LabCorp, Left Lane Capital and General Catalyst. The company has 9 employees as of December 31, 2023. Evvy offers products and services including Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories. Evvy operates in a competitive market with competitors including Viome, Flore, uBiome, Jona and Kean Health, among others.
- Headquarter New York, United States
- Employees 9 as on 31 Dec, 2023
- Founders Priyanka Jain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19 M (USD)
in 2 rounds
-
Latest Funding Round
$14 M (USD), Series A
Sep 27, 2023
-
Investors
LabCorp
& 10 more
-
Employee Count
9
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evvy
Evvy offers a comprehensive portfolio of products and services, including Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories.
At-home swab for analyzing vaginal microbiome and health outcomes.
Cream to soothe and relieve vulva irritation and discomfort.
Suppositories for maintaining vaginal moisture and health balance.
Suppositories to address imbalances in the vaginal microbiome.
People of Evvy
Unlock access to complete
Unlock access to complete
Funding Insights of Evvy
Evvy has successfully raised a total of $19M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Evvy
Evvy has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Left Lane Capital and General Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward high-growth consumer and internet technology companies.
|
Locked | Locked | Locked | |
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Locked | Locked | Locked | |
|
Investments are focused on reproductive healthcare startups by Rhia Ventures.
|
Locked | Locked | Locked |
Investor details for Evvy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evvy
Investment portfolio details for Evvy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Evvy
Detailed financials for Evvy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evvy Comparisons
Peer comparison for Evvy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evvy
Evvy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Flore, uBiome, Jona and Kean Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| Locked | Locked | Locked |
Customized probiotics for gut health are provided via stool analysis.
|
|
| Locked | Locked | Locked |
Provides comprehensive sequence datasets for human microbiome research and analysis.
|
|
| Locked | Locked | Locked |
AI-powered microbiome profiling platform to improve digestive health
|
|
| Locked | Locked | Locked |
At-home kits for gut microbiome, gene, and vaginal health testing services.
|
Detailed competitors of Evvy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evvy
Complete news archive for Evvy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evvy
Evvy was founded in 2002 and raised its 1st funding round 19 years after it was founded.
Evvy is headquartered in New York, United States. It is registered at New York, New York, United States.
Priyanka Jain is the current CEO of Evvy. They have also founded this company.
Evvy is a funded company, having raised a total of $19M across 2 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Evvy is 9.
Evvy was founded in 2002 in New York, United States, within the health technology sector. An online platform is maintained to distribute at-home test kits focused on vaginal microbiome analysis. Services include sample collection kits and diagnostic reporting, with operations centered in the U.S. to support womens health monitoring. The company is led by co-founder and CEO Priyanka Jain.
Evvy's top competitors include Viome, Flore and HyperSpectral.
Evvy offers Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories.
Evvy has 11 investors. Key investors include LabCorp, Left Lane Capital, General Catalyst, Rhia Ventures, and Ingeborg Investments.